What is NowRx?
NowRx operates at the intersection of health-tech and logistics, providing a streamlined, digital-first pharmacy experience designed to eliminate the friction associated with traditional medication procurement. By leveraging proprietary software for rapid fulfillment and precise delivery, the company addresses critical pain points in the pharmaceutical supply chain. Beyond mere logistics, NowRx distinguishes itself by offering a comprehensive repository of health insights, wellness education, and condition-specific guidance. This dual-pronged approach—combining operational efficiency with patient-centric health literacy—positions the company as a formidable player in the evolving digital pharmacy landscape, catering to a growing demographic that demands both convenience and expert-backed health support.
How much funding has NowRx raised?
NowRx has raised a total of $54.9M across 6 funding rounds:
Angel/Seed
$2M
Series A
$7M
Multiple Rounds
$23.4M
Series C
$22.5M
Angel/Seed (2017): $2M, investors not publicly disclosed
Series A (2018): $7M, investors not publicly disclosed
Debt (2020): $350K supported by PPP
Corporate Investment (2020): $3M featuring Decathlon Capital Partners LLC
Series B (2020): $20M, investors not publicly disclosed
Series C (2022): $22.5M, investors not publicly disclosed
Key Investors in NowRx
Decathlon Capital Partners LLC
A growth-focused investment firm specializing in revenue-based financing and non-dilutive capital solutions for high-growth companies.
PPP
Public-Private Partnership
Undisclosed Investor
Undisclosed investor participating in the funding round.
What's next for NowRx?
With the recent influx of capital, NowRx is well-positioned to scale its infrastructure and expand its geographic footprint. The company's strategic roadmap likely involves enhancing its automated fulfillment centers and deepening its integration with telehealth platforms to provide a more cohesive patient journey. As the digital health sector matures, NowRx is expected to leverage its data-driven insights to forge deeper partnerships with healthcare providers and insurers, further cementing its role as an essential component of the modern healthcare ecosystem. The focus will remain on optimizing the last-mile delivery experience while scaling the platform's capacity to handle increased prescription volume without compromising the accuracy and speed that define its value proposition.
See full NowRx company page
